NEYPPC Pharmacy - Unlicensed Imported Medicines (Wave 2)
In plain English
The notice doesn't say
Who holds it now
Last won by Clinigen Healthcare Limited and Mawdsley-Brooks & Co Ltd and Durbin PLC and 4 more in Mar 2026, for £27.4m.
- NEYPPC Pharmacy - Unlicensed Imported Medicines 2025Clinigen Healthcare Limited, Mawdsley-Brooks & Co Ltd, Durbin PLC and 4 more £27.4m
- Framework Agreement for the Supply of Unlicensed Imported Medicines Services and Products to Trusts within the North of England with the inclusion of mini competitions and/or direct awards.Target Healthcare Ltd, Eaststone Ltd, Alium Medical Ltd and 4 more £15.4m
What you're up against
- The same firms have won it the last 2 times Kestrel found: expect them to bid again, and to know the work well.
- 8 different firms won this buyer's 2 awards for this kind of work in 2026.
- It last went for £27.4m in 2026.
- The last award named 7 suppliers: it may be a framework, where many firms are chosen.
The notice as published
The North East and Yorkshire NHS Pharmaceutical Purchasing Consortium intends to run a further competition under its established Dynamic Market for the supply of Unlicensed Imported Medicines. This route enables flexible, efficient and sustainable sourcing by drawing on a continuously open pool of qualified suppliers. The requirement will cover the provision of unlicensed medicines imported from trusted countries, in accordance with UK regulatory standards. Suppliers will be required to hold all relevant licenses and approvals, and the necessary permissions to import and supply unlicensed medicines in the UK. The Dynamic Market will enable Trusts across the region to access safe, compliant, and competitively sourced unlicensed medicines, ensuring resilient supply routes and strong assurance of product quality.